Informações:
Falhas:
ID
16525
Descrição
Interferon-Alpha for Diabetes Mellitus Type 1; ODM derived from: https://clinicaltrials.gov/show/NCT00024518
Link
https://clinicaltrials.gov/show/NCT00024518
Palavras-chave
Versões (1)
- 22/07/2016 22/07/2016 -
Transferido a
22 de julho de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Insulin-Dependent Diabetes Mellitus NCT00024518
Eligibility Insulin-Dependent Diabetes Mellitus NCT00024518
- StudyEvent: Eligibility
Similar models
Eligibility Insulin-Dependent Diabetes Mellitus NCT00024518
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
t1dm of less than 6 weeks duration
Item
t1dm of less than 6 weeks duration in patients between 3 and 25 years of age.
boolean
C0011854 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0001779 (UMLS CUI [1,2])
besides t1dm, no concurrent illness.
Item
besides t1dm, no concurrent illness.
boolean
C0009488 (UMLS CUI [1])
treatment with immunosuppressive or immunostimulatory medications
Item
treatment with immunosuppressive or immunostimulatory medications such as azathioprine, nicotinamide, superoxide dismutase-desferroxamine, aminoguanidine, oral insulin or other experimental therapies at the present time or in the past.
boolean
C0021079 (UMLS CUI [1])
abnormal pre-treatment white blood cell count (wbc) or thrombocytopenia.
Item
abnormal pre-treatment white blood cell count (wbc) or thrombocytopenia.
boolean
C0023508 (UMLS CUI [1])
C0040034 (UMLS CUI [2])
C0040034 (UMLS CUI [2])
known active diseases
Item
known active diseases, e.g. cardiac, renal, hepatic diseases or immunodeficiency.
boolean
C2707252 (UMLS CUI [1])
comorbidities
Item
history of cancer, neuropathy seizure disorders (except typical history of febrile seizures in childhood), peripheral vascular disease, coagulation abnormalities, autoimmune disease (except type 1 diabetes) or cerebrovascular disease.
boolean
C0006826 (UMLS CUI [1])
C0027765 (UMLS CUI [2])
C0085096 (UMLS CUI [3])
C0004364 (UMLS CUI [4])
C0007820 (UMLS CUI [5])
C0027765 (UMLS CUI [2])
C0085096 (UMLS CUI [3])
C0004364 (UMLS CUI [4])
C0007820 (UMLS CUI [5])
ongoing use of medications except insulin
Item
ongoing use of medications known to influence glucose tolerance (e.g. sulfonylureas, metformin, diphenylhydantoin, thiazide or other potassium depleting diuretics, beta-adrenergic blockers, niacin) except insulin.
boolean
C0205420 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
medical condition compromising trial protocol
Item
any medical condition that, in the opinion of the investigator, will interfere with the safe completion of the trial.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
inability to give informed consent or assent.
Item
inability to give informed consent or assent.
boolean
C0021430 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
clinical trial participation status
Item
participation in a clinical trial within the previous 6 weeks.
boolean
C2348568 (UMLS CUI [1])
pregnant or lactating
Item
lactating or pregnant female individual (individuals will be advised not to volunteer for the protocol if they plan to become pregnant during the time of the study and they are instructed to use an effective method of contraception).
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
age
Item
age above 25 years, since there may be several subtypes of t1dm.
boolean
C0001779 (UMLS CUI [1])